Other helminthiases, including avohilmo

AB1_HELMINTHIASES_NOS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — B83 Hospital discharge: ICD-10 — B83 Hospital discharge: ICD-9 — 128 Hospital discharge: ICD-8 — 1289 Cause of death: ICD-10 — B83 Cause of death: ICD-9 — 128 Cause of death: ICD-8 — 1289 3 out of 7 registries used, show all original rules.	99
4. Check minimum number of events None	99
5. Include endpoints None	99
6. Filter based on genotype QC (FinnGen only)	90

Control definitions (FinnGen only)

Control exclude: AB1_HELMINTIASES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF13

NAME	AB1_HELMINTHIASES_NOS_WIDE
CONTROL_EXCLUDE	AB1_HELMINTIASES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	B83
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B83
HD_ICD_9	128
HD_ICD_8	1289
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B83
COD_ICD_9	128
COD_ICD_8	1289
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other helminthiases, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	90	59	31
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	49.36	47.80	52.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
96: Matched controls
960

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B83.9

ICD-10 Finland

Helminthiasis, unspecified

+∞

51.8

B83.8

ICD-10 Finland

Other specified helminthiases

+∞

13.9

12899

ICD-8 Finland

Other and unspecified helminthiasis, Unspecified

+∞

9.5

B83

ICD-10 Finland

Other helminthiases

+∞

9.5

B83.1

ICD-10 Finland

Gnathostomiasis

+∞

7.4

B83.0

ICD-10 Finland

Visceral larva migrans

+∞

7.4

B80

ICD-10 Finland

Enterobiasis

74.6

6.5

D01

ICPC

Abdominal pain/cramps general

3.8

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003327) Ova and parasites identified in Stool by Light microscopy

25.15

51.01

3.5

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

122

3.60

7.59

2.5

2.3

81.39

135.90

ug/g

0.58

(3007164) IgA [Mass/volume] in Serum or Plasma

204

2.65

4.96

2.7

1.4

2.90

2.48

g/l

0.27

122

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

222

2.59

4.82

1.5

1.3

0.63

1.41

u/ml

0.94

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

10.66

4.08

2.0

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

10.66

4.08

2.0

1.0

—

(3019198) Lymphocytes [#/volume] in Blood

444

2.44

4.03

10.2

7.3

1.87

1.95

e9/l

0.26

398

(3001604) Monocytes [#/volume] in Blood

435

2.41

4.00

10.1

7.3

0.50

0.57

e9/l

2.42

378

(3006315) Basophils [#/volume] in Blood

437

2.39

3.93

10.2

7.2

0.04

e9/l

0.60

379

(3022145) Colonoscopy Study observation

105

2.71

3.92

1.6

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

5.45

3.80

1.4

1.3

—

(3013115) Eosinophils [#/volume] in Blood

450

2.27

3.48

10.3

7.9

0.22

0.18

e9/l

0.68

397

(36660697) Celiac disease serology panel - Serum

2.61

3.20

1.1

1.2

—

(42870588) Differential panel, method unspecified - Blood

283

2.11

3.17

8.5

7.0

—

(3021589) Normoblasts [#/volume] in Blood

393

2.11

3.13

12.7

11.2

0.00

e9/l

-0.00

321

(3013650) Neutrophils [#/volume] in Blood by Automated count

477

2.12

2.95

16.3

11.6

3.64

4.11

e9/l

0.95

423

(40768797) Stomach Pathology biopsy report

113

2.36

2.92

1.2

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3.48

2.60

1.6

2.1

—

(3016018) Differential panel - Cerebral spinal fluid

5.73

2.58

1.5

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

5.25

2.44

1.2

1.0

—

(3017181) Myelocytes/Leukocytes in Blood

2.47

2.32

3.7

5.9

0.17

0.63

—

(3002179) Metamyelocytes/Leukocytes in Blood

2.52

2.27

3.2

6.2

0.00

0.85

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

141

2.05

2.25

2.0

2.1

—

(3021440) Promyelocytes/Leukocytes in Blood

2.43

2.13

3.9

6.1

0.00

0.05

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

5.20

2.09

1.2

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

5.20

2.09

1.2

1.4

—

(3023410) Appearance of Cerebral spinal fluid

4.19

2.07

1.8

2.4

—

(3025130) Human papilloma virus identified in Specimen

4.19

2.07

1.3

2.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

4.19

2.07

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.44

1.89

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.91

1.84

1.1

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.24

1.81

5.4

2.5

0.18

0.24

g/l

1.75

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

153

1.86

1.76

2.4

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

3.06

1.76

1.0

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.35

1.76

1.2

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

3.71

1.63

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

2.98

1.53

1.8

2.0

—

(40768443) Skin Pathology biopsy report

2.58

1.52

1.1

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

212

1.68

1.49

2.6

2.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

2.14

1.45

1.3

274.86

633.49

u/ml

0.36

(3024928) Oxygen saturation in Venous blood

2.60

1.32

1.0

2.8

60.55

63.56

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.40

1.30

1.6

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

416

1.55

1.27

5.8

6.7

1.23

1.22

mmol/l

0.59

369

(3019230) Fractional oxyhemoglobin in Venous blood

2.72

1.23

1.0

2.5

57.80

65.21

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.20

1.21

1.3

—

(3025941) Bacteria identified in Stool by Culture

2.12

1.21

1.2

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

188

1.61

1.19

6.7

5.9

—

(40768804) Tissue Pathology biopsy report

355

1.50

1.14

2.4

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.35

1.13

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

106

1.73

1.12

3.5

2.8

0.55

0.71

ug/l

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2.03

1.10

2.1

4.0

1.24

1.23

mmol/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.28

1.10

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.28

1.10

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.45

1.10

1.4

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

357

1.49

1.10

2.2

2.1

105.08

96.09

pmol/l

0.48

185

(3018095) Leukocytes [#/volume] in Urine

339

1.49

1.08

4.8

4.3

138.12

43.29

e6/l

0.55

226

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

158

1.60

1.07

1.4

1.6

—

(36304419) Bacteria [Presence] in Urine

249

1.50

1.01

3.8

3.1

—

estimate

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.95

1.01

1.1

1.2

—

(40758558) Short blood count panel - Blood

259

1.48

1.00

13.3

7.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

152

1.58

1.00

2.7

3.0

2.50

2.49

e6/l

0.00

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

187

1.54

0.99

1.3

11.03

32.25

iu/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.87

0.99

3.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

161

1.56

0.99

2.9

3.0

0.56

0.95

e6/l

0.75

(3011288) Drugs identified in Urine by Screen method Nominal

1.96

0.96

2.9

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

263

1.45

0.91

3.7

3.1

0.01

0.30

e6/l

3.53

186

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.00

0.86

1.0

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

203

1.46

0.83

2.2

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.93

0.83

1.8

2.0

29.67

37.78

nmol/l

—

(3015736) pH of Urine

375

1.38

0.78

4.5

3.7

6.24

6.21

0.04

202

(3018418) pH of Serum or Plasma

261

1.40

0.77

5.6

4.1

7.39

0.05

187

(3022313) Gas panel - Capillary blood

1.81

0.77

1.3

3.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2.14

0.75

1.8

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

300

1.38

0.75

3.6

3.4

105.98

50.90

e6/l

0.36

224

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

609

1.40

0.74

3.9

3.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1.64

0.73

2.1

2.4

12.72

16.13

nmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

128

1.50

0.72

1.7

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.67

0.72

1.1

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

120

1.51

0.70

1.6

2.0

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

785

1.56

0.68

17.9

14.5

88.46

85.04

ml/min/173m2

0.82

718

(3009261) Glucose [Presence] in Urine by Test strip

470

1.34

0.68

5.0

4.0

0.00

estimate

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.83

0.67

1.0

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1.62

0.65

1.1

1.3

44.20

118.65

u/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

464

1.32

0.62

4.8

3.9

0.00

estimate

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.70

0.62

1.0

1.1

—

5.38

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.53

0.62

1.5

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.61

0.0

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.60

0.0

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.76

0.59

2.3

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.62

0.55

2.2

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

136

1.40

0.54

3.7

3.8

15.20

21.09

—

(4024509) Urine culture

1.57

0.54

1.8

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.57

0.54

1.5

47.37

63.96

ug/l

—

(1761868) Lipid panel - Serum or Plasma

334

1.28

0.52

4.0

2.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

192

1.33

0.52

1.7

1.9

0.95

0.94

mg/l

0.00

152

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

175

1.33

0.49

2.2

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.53

0.49

2.0

4.8

23.66

24.63

mmol/l

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1.43

0.46

1.7

2.4

—

70.62

—

(4035726) Immunohistochemistry procedure

1.46

0.45

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

234

1.28

0.44

1.9

1.7

23.03

22.29

nmol/l

0.10

199

(3035350) Ketones [Presence] in Urine by Test strip

468

1.24

0.44

5.0

3.9

0.00

estimate

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.41

0.0

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.41

0.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

135

0.71

0.39

1.5

2.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

305

0.80

0.39

5.0

3.3

115.71

33.47

ng/l

0.62

202

(3024354) Oxygen [Partial pressure] in Venous blood

1.36

0.39

2.0

3.5

4.42

4.72

kpa

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

200

1.27

0.39

2.3

2.4

—

(3026008) Bacteria identified in Urine by Culture

257

1.24

0.39

2.7

3.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

108

1.35

0.38

1.4

2.1

1.74

1.35

1.76

(3007853) Bacteria identified in Skin by Aerobe culture

1.36

0.38

2.2

1.6

—

(3013512) EKG study

262

0.79

0.37

4.9

3.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.49

0.37

1.8

2.4

0.65

1.29

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

816

1.36

0.36

19.6

17.0

139.92

139.74

mmol/l

0.31

799

(3027008) Opiates [Presence] in Urine

1.46

0.36

2.5

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1.46

0.36

2.5

1.2

—

(3027944) Amphetamines [Presence] in Urine

1.46

0.36

2.5

1.2

—

(3016879) Cocaine [Presence] in Urine

1.46

0.36

2.5

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.46

0.36

1.8

2.4

0.47

0.60

—

(3000764) Benzodiazepines [Presence] in Urine

1.42

0.36

2.5

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

817

1.35

0.35

19.9

17.2

3.87

3.94

mmol/l

1.72

798

(3003694) ABO and Rh group [Type] in Blood

260

1.22

0.34

1.6

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

214

1.23

0.32

2.6

3.4

950.50

979.50

ng/l

0.03

184

(3044640) Blood type and Crossmatch panel - Blood

272

1.21

0.31

2.4

—

(3032080) INR in Blood by Coagulation assay

350

1.19

0.31

9.2

10.7

1.14

1.19

inr

0.31

287

(40761536) Microorganisms panel - Urine sediment

1.27

0.28

6.9

3.9

—

(3000991) Gas panel - Venous blood

1.26

0.26

1.7

8.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

873

0.77

0.25

17.5

11.6

25.61

25.80

u/l

0.04

855

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.37

0.24

1.8

1.1

1.51

1.58

g/l

—

(3000492) Spirometry study

1.28

0.24

1.9

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.74

0.23

1.1

1.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.33

0.23

1.8

1.1

1.02

0.88

g/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

865

1.40

0.23

23.1

18.8

71.83

74.41

umol/l

0.71

849

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

8.4

—

0.56

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.21

0.0

1.4

—

6.08

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.21

0.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.21

0.0

2.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.21

0.0

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.21

0.0

2.0

—

1080.60

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

0.21

0.0

1.5

—

13.50

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.21

0.0

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

2.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.6

—

0.17

—

(3002256) Pathology report gross observation

100

1.23

0.19

1.4

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1.22

0.18

1.1

1.2

—

37.58

—

(3009508) Creatinine [Moles/volume] in Urine

274

1.14

0.18

4.0

3.2

9.00

7.87

mmol/l

0.64

230

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.16

0.18

1.4

1.5

836.16

948.32

mu/l

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

899

0.86

0.18

32.5

23.3

90.88

90.79

0.08

889

(3010813) Leukocytes [#/volume] in Blood

899

0.86

0.18

32.7

23.3

6.09

6.68

e9/l

2.78

879

(3007461) Platelets [#/volume] in Blood

899

0.86

0.18

32.6

23.4

244.72

255.48

e9/l

0.91

881

(3026361) Erythrocytes [#/volume] in Blood

899

0.86

0.18

32.6

23.3

4.46

4.49

e12/l

0.30

880

(3035941) MCH [Entitic mass]

899

0.86

0.18

32.6

23.2

30.21

30.25

0.09

889

(3000963) Hemoglobin [Mass/volume] in Blood

899

0.86

0.18

32.9

23.5

134.45

135.17

g/l

0.19

889

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

899

0.86

0.18

32.6

23.7

40.06

40.49

0.31

888

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.73

0.17

2.2

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

830

1.21

0.17

20.6

15.4

21.17

24.31

mg/l

0.34

682

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.14

0.15

1.9

2.1

—

(3002032) Base excess in Venous blood by calculation

1.12

0.15

1.8

4.5

0.49

2.31

mmol/l

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.12

0.15

2.0

4.5

5.71

5.69

kpa

—

(3019150) Specific gravity of Urine by Refractometry

201

0.87

0.15

3.8

1.02

kg/l

—

130

(3042936) Bacteria identified in Isolate by Culture

128

0.84

0.14

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

0.83

0.14

1.6

1.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

106

1.15

0.10

3.6

6.9

104.92

104.21

mmol/l

0.25

106

(3001019) Free T4 and TSH panel - Serum or Plasma

1.17

0.10

1.4

1.7

—

(1002224) Polysomnography panel

1.09

0.10

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

136

1.12

0.09

1.8

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

256

0.92

0.09

4.9

3.8

0.00

estimate

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.08

0.09

1.0

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.12

0.08

1.4

7.5

1.09

1.11

mmol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

255

0.92

0.08

5.0

3.3

0.11

0.00

estimate

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

108

1.13

0.07

5.2

6.0

1.01

1.06

mmol/l

0.37

100

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.08

0.07

1.6

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

101

0.88

0.06

5.7

4.3

33.78

32.46

—

(3000494) Fungus identified in Specimen by Culture

103

0.86

0.06

1.3

1.5

—

(3023368) Bacteria identified in Blood by Culture

232

0.93

0.05

3.6

4.2

—

(21494755) Public health laboratory ask at order entry panel

1.10

0.03

1.4

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

252

1.04

0.02

5.1

4.0

2.66

11.53

mg/mmol

2.12

159

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

341

1.00

0.00

4.8

3.8

0.00

estimate

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

391

1.00

0.00

3.1

2.8

—

estimate

—

(3031040) Bacteria [#/volume] in Urine by Automated count

565

1.02

0.00

6.5

4.8

—

83.80

—

(3012516) Albumin [Mass/volume] in Urine

245

1.03

0.00

4.2

3.6

17.07

68.89

mg/l

2.19

162

(40761511) CBC panel - Blood by Automated count

851

0.99

0.00

14.1

12.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.26

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.8

—

32.31

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.5

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

2.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.0

—

(44813793) Dust mix specific IgE antibody measurement

0.00

-0.00

0.0

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

3.2

—

97.80

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.98

-0.00

1.4

1.6

—

4.12

—

(4198724) Urine methamphetamine measurement

0.00

-0.00

0.0

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

2.8

—

81.00

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

7.02

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

13.00

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

2.4

—

6.54

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

3.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

3.06

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

3.3

—

89.46

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

101.11

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.3

—

31.83

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

0.97

-0.00

5.5

3.6

4.67

4.32

pmol/l

—

(44806420) Estimation of glomerular filtration rate

0.00

-0.00

0.0

1.8

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.2

—

15.64

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

2.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

5.8

—

215.17

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.3

—

252.57

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.6

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

4.4

—

(3012441) Differential panel - Pleural fluid

0.00

-0.00

0.0

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

-0.00

0.0

1.4

—

15.80

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

10.21

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3035880) pH of Pleural fluid

0.00

-0.00

0.0

1.2

—

7.34

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

-0.00

0.0

4.4

—

51.00

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

165.78

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_HELMINTHIASES_NOS_WIDE – Other helminthiases, including avohilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other helminthiases, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other helminthiases, including avohilmo (AB1_HELMINTHIASES_NOS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints